PIA
NYMX

Piedmont Investment Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Piedmont Investment Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-562
Closed -$2K – 2491
2018
Q2 		$2K Buy
+562
New +$2.16K ﹤0.01% 2669

Other funds holding NYMX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Piedmont Investment Advisors's NYMX Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2018, closing a stake of 562 shares — an estimated $2K sold.

Piedmont Investment Advisors first reported a position in NYMX in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 46 funds tracked by Wall St. Rank hold NYMX as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Nymox Pharmaceutical Corp position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 562 Nymox Pharmaceutical Corp shares in Q3 2018, an estimated $2K.
  • Piedmont Investment Advisors first reported a position in Nymox Pharmaceutical Corp in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Nymox Pharmaceutical Corp position peaked at $2K in Q2 2018.
  • 46 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.